PMOS: Kaletra Double Protease Inhibitors.
Phase of Trial: Phase IV
Latest Information Update: 14 Jan 2013
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Peptide hydrolase inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PMOS
- Sponsors Abbott Laboratories
- 10 Jun 2017 Biomarkers information updated
- 22 Mar 2012 Actual patient number changed from 70 to 65 as reported by ClinicalTrials.gov.
- 13 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.